Accession Number: | 0001213900-22-019969 |
Date: | 2022-04-14 |
Issuer: | ENZO BIOCHEM INC (ENZ) |
Original Submission Date: |
RADOFF BRADLEY LOUIS
C/O ENZO BIOCHEM, INC.
527 MADISON AVENUE
NEW YORK, NY 10022
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, $0.01 PAR VALUE | 2022-04-14 | A | 30,000 | a | $2.91 | 430,000 | indirect | ||
COMMON STOCK, $0.01 PAR VALUE | 2022-04-14 | 0 | $0.00 | 3,898,100 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the shares of common stock are directly held by the radoff family foundation (the "radoff foundation"). mr. radoff is a director of the radoff foundation and may be deemed to beneficially own the shares of common stock held by the radoff foundation. mr. radoff disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
f2 | the price reported in column 4 is a weighted average price. these shares were purchased in multiple transaction prices ranging from $2.91 to $2.9155 inclusive. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |